MRK Stock Summary and Trading Ideas (Merck Common (New) | NYSE:MRK)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

What symbol and exchange does Merck Common (New) shares trade?

Merck Common (New) trades on the NYSE stock market under the symbol MRK.

What is Merck Common (New) stock price doing today?

As of October 8, 2026, MRK stock price declined to $140.77 with 2,999,805 million shares trading.

What is Merck Common (New)'s Beta?

MRK has a beta of -0.21, meaning it tends to be less sensitive to market movements. MRK has a correlation of 0.01 to the broad based SPY ETF.

How much is Merck Common (New) worth?

MRK has a market cap of $347.30 billion. This is considered a Mega Cap stock.

How much money does Merck Common (New) make?

Last quarter Merck Common (New) reported $17 billion in Revenue and -$.13 earnings per share. This beat revenue expectation by $219 million and missed earnings estimates by -$.36.

What is the highest and lowest price Merck Common (New) traded in the last 3 year period?

In the last 3 years, MRK traded as high as $156.92 and as low as $73.31.

What are the top ETFs holding Merck Common (New)?

The top ETF exchange traded funds that MRK belongs to (by Net Assets): VTI, VOO, IVV, SCHD, SPY.

Is Merck Common (New) (MRK) a good investment?

MRK has outperformed the market in the last year with a return of +64.6%, while the SPY ETF gained +16.4%. In the last 3 month period, MRK beat the market returning +9.9%, while SPY returned +3.4%. However, in the most recent 2 weeks MRK has underperformed the stock market by returning -4.9%, while SPY returned +0.5%.

What are the support and resistance levels for Merck Common (New) (MRK)?

MRK support price is $140.47 and resistance is $145.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRK shares will trade within this expected range on the day.